As developed in Section 3.5, in the frame of the RIANS model, abnormal MRE11 activity and abnormal MRE11 foci kinetics appear to be correlated to the hyper-recombination phenomenon and cancer proneness, but not necessarily to toxicity [13,30,50]. The gene discussed is MRE11; the disease is cancer.